Online-Only Abstracts  by unknown
Online-Only Abstracts
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Abstract
Hand, foot and mouth disease (HFMD) is a childhood illness frequently caused by genotypes belonging to the enterovirus A species, including
coxsackievirus (CV)-A16 and enterovirus (EV)-71. Between 2010 and 2012, several outbreaks and sporadic cases of HFMD occurred in
different regions of Spain. The objective of the present study was to describe the enterovirus epidemiology associated with HFMD in the
country. A total of 80 patients with HFMD or atypical rash were included. Detection and typing of the enteroviruses were performed directly
in clinical samples using molecular methods. Enteroviruses were detected in 53 of the patients (66%). CV-A6 was the most frequent genotype,
followed by CV-A16 and EV-71, but other minority types were also identiﬁed. Interestingly, during almost all of 2010, CV-A16 was the only
causative agent of HFMD but by the end of the year and during 2011, CV-A6 became predominant, while CV-A16 was not detected. In 2012,
however, both CV-A6 and CV-A16 circulated. EV-71 was associated with HFMD symptoms only in three cases during 2012. All Spanish CV-A6
sequences segregated into one major genetic cluster together with other European and Asian strains isolated between 2008 and 2011, most
forming a particular clade. Spanish EV-71 strains belonged to subgenogroup C2, as did most of the European sequences circulated. In
conclusion, the recent increase of HFMD cases in Spain and other European countries has been due to a larger incidence of circulating species
A enteroviruses, mainly CV-A6 and CV-A16, and the emergence of new genetic variants of these viruses.
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Abstract
HIV quasispecies was analysed in plasma and proviral genomes hosted by duodenal mucosa and peripheral blood cells (PBMC) from
patients with early or chronic infection, with respect to viral heterogeneity, tropism compartmentalization and extent of immune
activation. Seventeen HIV-1-infected combined antiretroviral therapy naive patients were enrolled (11 early infection and six chronic
infection). V3 and nef genomic regions were analysed by ultra-deep pyrosequencing. Sequences were used to infer co-receptor usage and
to construct phylogenetic trees. As markers of immune activation, plasma sCD14 and soluble tumour necrosis factor receptor II
(sTNFRII) levels were measured. Median diversity of HIV RNA was lower in patients with early infection versus chronic infection
patients. Overall, direct correlation was observed between V3 diversity and X4 frequency; V3 diversity of HIV RNA was inversely
correlated with CD4 T-cell count; median sCD14 and sTNFRII values were similar in early and chronic patients, but X4 frequency of HIV
RNA was directly correlated with plasma sCD14. The proportion of patients harbouring X4 variants and median intra-patient X4
frequency of proviral genomes tended to be higher in chronic infection than early infection patients. More pronounced
compartmentalization of proviral quasispecies in gut compared with PBMC samples was observed in patients with early infection
compared with chronic patients. The loss of gut/PBMC compartmentalization in more advanced stages of HIV infection was conﬁrmed by
longitudinal observation. More studies are needed to understand the pathogenetic signiﬁcance of early HIV quasispecies compartmen-
talization and progressive intermixing of viral variants in subsequent phases of the infection, as well as the role of immune activation in
tropism switch.
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Abstract
Dengue fever represents a major public health problem. Both viral and host immune factors are involved in severe infections. Humans
and mosquito-vectors are infected with diverse viral populations that may play a role in viral adaptation and disease pathogenesis. Our
objective was to analyse the intra-host genetic variability of dengue virus type 1 (DENV-1) in the venous and capillary blood and its
relationships with the clinical presentation of dengue fever. Early serum samples were collected in 2009 from ten DENV-1-infected
patients hospitalized in Santa Cruz de la Sierra, Bolivia. Partial viral envelope sequences were analysed at the inter-host and intra-host
level. For each patient, an average of 56 clone sequences was analysed both in the venous sector and the capillary sector (from right and
left hands). The ten consensus sequences were highly similar. The intra-host DENV-1 genetic variability was signiﬁcantly lower in the
venous sector than in the capillary sector, and in patients with haemorrhagic symptoms than in those without haemorrhagic symptoms,
particularly in capillary samples. No relation was found with sex, age, dengue IgG-serological status, day of serum sampling, or viral load.
Signiﬁcant relationships were found between the clinical presentation of dengue fever and the variability of viral populations within hosts,
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particularly in capillary samples. The observed variability of envelope sequences at the early phase of dengue infection was not critically
inﬂuenced by the previous dengue serological status of patients. An important part of viral microevolution may occur in the capillary
sector and inﬂuence the mechanisms of severe forms.
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